Arcturus Therapeutics Holdings Inc. ARCT
9.31 USD -0.08 (-0.85%)
At closeNov 12, 2026, 4:31 AM EST
9.39 +0.08 +0.86%
Pre-market · Nov 12, 4:31 AM ET
9.14 Day range 9.67
5.50 52-week range 17.96
- YTD
- +51.88%
- 1 year
- +7.38%
News
seekingalpha.com Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2026 Earnings Call Transcript Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2026 Earnings Call Transcript
marketbeat.com What Arcturus Therapeutics (ARCT) Said on Its Q3 Earnings Call Arcturus Therapeutics NASDAQ: ARCT expects to complete enrollment in a mid-stage cystic fibrosis study by the end of 2026 and begin dosing a next-generation treatment for a rare liver disorder in the…
zacks.com Arcturus Therapeutics (ARCT) Reports Q3 Loss, Beats Revenue Estimates Arcturus Therapeutics (ARCT) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.6. This compares to a loss of $0.49 per share a year ago.
benzinga.com Arcturus Therapeutics Q3 2026 Earnings Call Transcript Arcturus Therapeutics (NASDAQ:ARCT) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
benzinga.com Arcturus Therapeutics Q3 EPS $(0.26) Beats $(0.68) Estimate, Sales $18.297M Beat $7.998M Estimate Arcturus Therapeutics (NASDAQ:ARCT) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.68) by 61.76 percent. This is a 46.94 percent increase over losses…
businesswire.com Arcturus Therapeutics Announces Third Quarter 2026 Financial Results and Pipeline Progress SAN DIEGO--(BUSINESS WIRE)---- $ARCT #65Roses--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and…
benzinga.com Transcript: Arcturus Therapeutics Q2 2026 Earnings Conference Call Arcturus Therapeutics (NASDAQ:ARCT) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs.…